EBoDE Data Overview: Difference between revisions
No edit summary |
(Template:ebode added) |
||
Line 1: | Line 1: | ||
{{ebode}} | |||
{{study|moderator=Mori|stub=Yes}} | {{study|moderator=Mori|stub=Yes}} | ||
[[category:EBoDE]] | [[category:EBoDE]] |
Latest revision as of 14:10, 19 November 2012
This page is a product of the EBoDE project. The final report of the EBoDE project has been published as a report in 2011[1] and also as web pages in Opasnet. These links lead to parts of the report.
EBoDE project: main page | overview | contributors | data overview | Parma meeting | abbreviations | all pages Methods: environmental burden of disease calculation | selection of exposures and health effects | data needed | impact calculation tool Health effects in Europe: benzene | dioxins | formaldehyde | lead | ozone | particulate matter | radon | second-hand smoke | transport noise | environmental burden of disease | results by country |
This page is a study.
The page identifier is Op_en5232 |
---|
Moderator:Mori (see all) |
This page is a stub. You may improve it into a full page. |
Upload data
|
Tables
Table 1
Stressor | Health endpoint | Population | Exposure estimate | Unit of exposure | Type of ERF | Point estimate of ERFa) | LCL (95%) | UCL (95%) | Reference(s) for ERF | Threshold | Calculation methodb) |
---|---|---|---|---|---|---|---|---|---|---|---|
Benzene | Leukemia | All | Annual mean exposure | µg m-3 | UR | 6.00 x 10-6 | 2.20 x 10-6 | 7.80 x 10-6 | WHO, 2000a; IRIS 2003 | 2A | |
Dioxin | Total cancer incidence | All | Daily intake of adults | pg/kg/d | UR | 1.00 x 10-3 | 5.70 x 10-4 | 5.10 x 10-3 | NAS, 2004, IRIS, 2006, Leino 2008 | 2A | |
SHS | Tracheas, bronchus and lung cancers c) | Adult non-smokers | % of people exposed (=yes) | yes/no | RR | 1.21 | 1.13 | 1.30 | US S.G., 2006 | 1A | |
Ischemic heart disease | Adult non-smokers | yes/no | RR | 1.27 | 1.19 | 1.36 | US S.G., 2006 | 1A | |||
Asthma induction | Adult non-smokers | yes/no | RR | 1.97 | 1.19 | 3.25 | Jaakkola et al., 2003 | 1A | |||
Asthma induction | Children (<14 yr) | parental y/n |
RR | 1.32 | 1.24 | 1.41 | Cal-EPA, 2005 | 1A | |||
Lower respiratory infections | Infants (<2 yr) | Parental y/n |
RR | 1.55 | 1.42 | 1.69 | US S.G., 2006 | 1A | |||
Otitis media | Toddlers (<3 yr) | Parental y/n |
RR | 1.38 | 1.21 | 1.56 | Etzel et al., 1992; Cal-EPA 2005 | 1A | |||
Formaldehyde | Asthma aggravation (children) (morbidity only) |
Toddlers (<3 yr) | Annual mean residential indoor concentration | µg m-3 | RR | 1.017 | 1.004 | 1.025 | Rumchev et al., 2002 | 100 | 1A |
Lead | IQ loss | Children (<5 yr) | Distribution of blood lead levels | µg/l | UR | 0.051 | 0.032 | 0.07 | Landphear et al., 2005 | 24 | 2B |
Mild mental retardation (morbidity only) |
Children (<5 yr) | µg/l | DS d) | function | - | - | - | 24 | 2B | ||
Hypertensive diseases (morbidity only) |
Adults/All | µg/l | DS d) | function | - | - | - | 50 | 2B | ||
Increased blood pressure | Adults/All | µg/l | UR | 2.50 x 10-2 | 1.70 x 10-2 | 3.20 x 10-2 | Fewtrell et al. 2003, Schwartz, 1995 | 50 | 2B | ||
Road traffic noise | High sleep disturbance (HSD) (morbidity only) |
All | Persons exposed to predefined exposure categories | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B | |
Ischemic heart disease (IHD) | All | Lday16h (dB) | OR | function | function | function | Babisch, 2006 | 1A | |||
Railway noise | High sleep disturbance (HSD) (morbidity only) |
All | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B | ||
Aircraft noise | High sleep disturbance (HSD) (morbidity only) |
All | Lnight (dB) | UR | function | function | function | Miedema et al., 2007 | 2B | ||
Ozone | Total mortality (non-violent) | Adults (>30 yr) | Population weighed ambient SOMO35 level |
µg m-3 | RR | 1.0003 | 1.0001 | 1.000 | WHO, 2006a | 1A | |
Minor restricted activity days (morbidity only) |
Working age (18–64 yr) |
µg m-3 | UR | 0.0115 | 0.0044 | 0.02 | Hurley et al., 2005, WHO 2006b | 2B | |||
Cough days, children (morbidity only) |
School children (5–14) |
µg m-3 | UR | 0.093 | 0.019 | 0.22 | Hurley et al., 2005, WHO 2006b | 2B | |||
LRS days in children (excl cough) (morbidity only) |
School children (5–14) |
µg m-3 | UR | 0.016 | -0.043 | 0.08 | Hurley et al., 2005, WHO 2006b | 2B | |||
PM2.5 | Cardiopulmonary disease | Adults (>30 yr) | Population weighted ambient level |
µg m-3 | RR | 1.0077 | 1.0020 | 1.0132 | Pope et al., 2002, WHO, 2006a | 1A | |
Lung cancer | Adults (>30 yr) | µg m-3 | RR | 1.012 | 1.004 | 1.020 | Pope et al., 2002, WHO, 2006a | 1A | |||
Chronic bronchitis (new cases) |
Adults (>27 yr) | µg m-3 | UR | 5.33 x 10-5 | 1.70 x 10-6 | 1.13 x 10-4 | Hurley et al., 2005, WHO, 2006b | 1A | |||
Restricted activity days (RAD) | 15–64 yr | µg m-3 | UR | 0.0902 | 0.0792 | 0.101 | Hurley et al., 2005, WHO, 2006b | 2B | |||
Radon | Lung cancer | All | Residential mean level |
Bq m-3 | RR | 1.0016 | 1.0005 | 1.0031 | Darby et al. 2005 | 1A |
a) These exposure response functions are all expressed per 1 unit of exposure.
b) Different types of calculation methods were applied (see also paragraph 2.1):
- 1A: Deriving the PAF from epidemiological data; applying the PAF to total burden of disease data (WHO database)
- 2A: Indirectly calculating the PAF from the Unit Risk and background incidence; applying the PAF to total burden of disease data (WHO database)
- 2B: Using a Unit Risk to calculate Attributable Incidence; calculating the Burden of Disease: AI x DW x L
c) The RR for spousal smoking is used as a proxy for any regular exposure (including at work).
d) For lead, a shift in exposure distributions is linked to a unit risk approach. Further information provided in 3.6.
Function: No point estimate can be given, as the exposure response function is given by a more complex function.
AI = Attributable Incidence;
ARI = Acute respiratory infections;
Bq = Becquerel;
IHD = Ischemic heart disease;
Lday16h = noise level for day and evening;
LRS = Lower respiratory Symptoms;
PCB = Polychlorinated biphenyls,
PAF = Population Attributable Fraction;
PM = Particulate Matter;
RAD = Restricted activity days;
SHS = Second-Hand Smoke,
SOMO35 = sum of maximum 8-hour ozone levels over 35 ppb (70 µg/m3);
UR = Unit Risk;
RR = Relative Risk;
yr = year; µg = microgram; mg = milligram; pg = picogram; kg = kilogram; d = day
Table 2
Stressor | Year(s) of original exposure data |
Assumptions for trends estimation to 2004 |
Exposure data source |
---|---|---|---|
Benzene | 2004 | National trend estimates when applicable |
AirBase data for outdoor levels in 2004; national studies for indoors |
Dioxins | 1997–2006 | No trend assumed | National data for intake |
Second-hand smoke | 2008 | Available data fitted with power functions for trends |
National and international survey data for exposures between 1990 and 2008 used for modelling 2004 data; |
Formaldehyde | 1990–2005 | No trend assumed | National indoor concentration data |
Lead | 1990–2005 | National trend estimates |
National blood lead level data |
Transport noise | 20071 | No trend assumed | EC Environmental Noise Directive data |
Ozone | 2005 | No trend assumed | ECT/ACC spatial model based on AirBase observations and air quality maps |
Particulate matter | 2005 | No trend assumed | |
Radon | up-to 2005 | No trend assumed | RadonMapping project (http://radonmapping.jrc.ec.europa.eu) and the UNSCEAR 2000 Report |
1 Target year of END data was set as 2007. The actual collected data contains subsets of data from various years.
Table 3
Environmental stressor | Population group | Exposure metric | Unit | Belgium | Finland | France | Germany | Italy | Netherlands |
---|---|---|---|---|---|---|---|---|---|
Benzene | All | Average annual exposure concentration | µg m-3 | 1.5 | 2.0 | 2.1 | 1.8 | 2.9 | 0.9 |
Dioxins and dioxin-like PCBs | All | Average annual daily intake | pg TEQ/kg/d | 1.9 | 1.5 | 2.3 | 2.0 | 2.3 | 1.0 |
SHS | All | Percentage of non-smokers | % | 74.9 | 74.2 | 71.5 | 71.0 | 76.5 | 66.6 |
Non-smokers | Percentage of non-smokers exposed | % | 32 | 14 | 25 | 31 | 30 | 30 | |
Children | Percentage of non-smokers exposed | % | NA | 4 | 33 | 24 | 40 | 36 | |
Formaldehyde (threshold 100 µg m-3) | All | Percentage of people exposed above 100 µg m-3 | % | 0.20 | 2.30 | 0.20 | 0.30 | 0.05 | 0.05 |
All | Average indoor concentration above 100 µg m-3 | µg m-3 | 139 | 122 | 118 | 113 | 101 | 101 | |
Lead | All | Average blood concentration? | µg/l | 22 | 16 | 25 | 22 | 39 | 19 |
Adults | Percentage of adults exposed above 50 µg/l | % | 5.5 | 1.8 | 8.1 | 5.5 | 23.9 | 3.4 | |
Adults | Average blood concentration for adults above 50 µg/l | µg/l | 68 | 68 | 68 | 67 | 76 | 65 | |
Children 0–4 | Percentage of children exposed above 24 µg/l | % | 32.5 | 17.0 | 39.9 | 32.5 | 67.1 | 24.7 | |
Children 0–4 | Average blood concentration for children above 24 µg/l | µg/l | 39 | 36 | 41 | 39 | 50 | 37 | |
Ozone | All | Annual sum of ozone maximum 8-h levels above 35 ppb (SOMO35) | µg m-3 | 2 787 | 2 580 | 4 756 | 4 164 | 8 134 | 1 920 |
PM2.5 | All | Average annual ambient concentration | µg m-3 | 18.7 | 9.1 | 12.3 | 16.0 | 19.6 | 18.7 |
PM10 | All | Average annual ambient concentration | µg m-3 | 28.9 | 13.3 | 19.1 | 22.1 | 32.7 | 29.1 |
Radon | All | Average annual indoor concentration | Bq m-3 | 69 | 120 | 89 | 50 | 70 | 30 |
- Noise data are not included in this overview table, as they cannot be easily summarized due to categorial exposures. For noise data, please see paragraph 3.7.
References
- ↑ 1.0 1.1 Otto Hänninen, Anne Knol: European Perspectives on Environmental Burden of Disease: Esimates for Nine Stressors in Six European Countries,
Authors and National Institute for Health and Welfare (THL), Report 1/2011 [1] [2] Cite error: Invalid
<ref>
tag; name "EBoDe" defined multiple times with different content